# Williams Companies, Inc.: financial statements, quarterly

WMB · NYSE · CIK 107263 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wmb.md) · [Financials](/companies/wmb/financials.md) · [Filings](/companies/wmb/filings.md) · [Insiders](/companies/wmb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wmb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,061](/filings/0000107263-24-000095.md) | [3,021 d](/filings/0000107263-26-000006.md) | [3,339](/filings/0000107263-25-000102.md) | [2,847](/filings/0000107263-25-000123.md) | [3,035](/filings/0000107263-25-000145.md) | [3,411 d](/filings/0000107263-26-000006.md) | [4,187](/filings/0000107263-26-000017.md) | [3,378](/filings/0000107263-26-000026.md) | [3,491](/filings/0000107263-25-000145.md) | [3,843 d](/filings/0000107263-26-000006.md) | [4,718](/filings/0000107263-26-000017.md) | [3,379](/filings/0000107263-26-000026.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [146](/filings/0000107263-24-000095.md) | [182 d](/filings/0000107263-25-000031.md) | [186](/filings/0000107263-25-000102.md) | [164](/filings/0000107263-25-000123.md) | [170](/filings/0000107263-25-000145.md) | [188 d](/filings/0000107263-25-000031.md) | [194](/filings/0000107263-25-000102.md) | [168](/filings/0000107263-25-000123.md) | [168](/filings/0000107263-25-000145.md) | not reported | not reported | not reported |
| Operating income | $m | [994](/filings/0000107263-24-000095.md) | [1,087 d](/filings/0000107263-26-000006.md) | [1,012](/filings/0000107263-25-000102.md) | [696](/filings/0000107263-25-000123.md) | [838](/filings/0000107263-25-000145.md) | [793 d](/filings/0000107263-26-000006.md) | [1,094](/filings/0000107263-26-000017.md) | [945](/filings/0000107263-26-000026.md) | [1,109](/filings/0000107263-25-000145.md) | [1,048 d](/filings/0000107263-26-000006.md) | [1,321](/filings/0000107263-26-000017.md) | [1,182](/filings/0000107263-26-000026.md) |
| Interest expense | $m | [314](/filings/0000107263-23-000027.md) | [322 d](/filings/0000107263-24-000019.md) | [349](/filings/0000107263-24-000063.md) | [339](/filings/0000107263-24-000077.md) | [338](/filings/0000107263-25-000145.md) | [338 d](/filings/0000107263-26-000006.md) | [349](/filings/0000107263-26-000017.md) | [350](/filings/0000107263-26-000026.md) | [372](/filings/0000107263-25-000145.md) | [371 d](/filings/0000107263-26-000006.md) | [376](/filings/0000107263-26-000017.md) | [371](/filings/0000107263-26-000026.md) |
| Income tax | $m | [176](/filings/0000107263-24-000095.md) | [370 d](/filings/0000107263-26-000006.md) | [193](/filings/0000107263-25-000102.md) | [129](/filings/0000107263-25-000123.md) | [227](/filings/0000107263-25-000145.md) | [91.0 d](/filings/0000107263-26-000006.md) | [193](/filings/0000107263-26-000017.md) | [174](/filings/0000107263-26-000026.md) | [246](/filings/0000107263-25-000145.md) | [244 d](/filings/0000107263-26-000006.md) | [244](/filings/0000107263-26-000017.md) | [260](/filings/0000107263-26-000026.md) |
| Net income | $m | [654](/filings/0000107263-24-000095.md) | [1,138 d](/filings/0000107263-26-000006.md) | [632](/filings/0000107263-25-000102.md) | [401](/filings/0000107263-25-000123.md) | [706](/filings/0000107263-25-000145.md) | [486 d](/filings/0000107263-26-000006.md) | [691](/filings/0000107263-26-000017.md) | [546](/filings/0000107263-26-000026.md) | [647](/filings/0000107263-25-000145.md) | [734 d](/filings/0000107263-26-000006.md) | [865](/filings/0000107263-26-000017.md) | [827](/filings/0000107263-26-000026.md) |
| Diluted EPS | $ per share | [0.54](/filings/0000107263-24-000095.md) | not reported | [0.52](/filings/0000107263-25-000102.md) | [0.33](/filings/0000107263-25-000123.md) | [0.58](/filings/0000107263-25-000145.md) | not reported | [0.56](/filings/0000107263-26-000017.md) | [0.45](/filings/0000107263-26-000026.md) | [0.53](/filings/0000107263-25-000145.md) | not reported | [0.70](/filings/0000107263-26-000017.md) | [0.68](/filings/0000107263-26-000026.md) |
| Basic EPS | $ per share | [0.54](/filings/0000107263-24-000095.md) | not reported | [0.52](/filings/0000107263-25-000102.md) | [0.33](/filings/0000107263-25-000123.md) | [0.58](/filings/0000107263-25-000145.md) | not reported | [0.57](/filings/0000107263-26-000017.md) | [0.45](/filings/0000107263-26-000026.md) | [0.53](/filings/0000107263-25-000145.md) | not reported | [0.71](/filings/0000107263-26-000017.md) | [0.68](/filings/0000107263-26-000026.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [2.1](/filings/0000107263-23-000027.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $bn | [4.3](/filings/0000107263-23-000027.md) | [4.5](/filings/0000107263-26-000006.md) | [2.6](/filings/0000107263-24-000063.md) | [2.1](/filings/0000107263-24-000077.md) | [2.7](/filings/0000107263-24-000095.md) | [2.7](/filings/0000107263-26-000006.md) | [2.5](/filings/0000107263-25-000102.md) | [3.2](/filings/0000107263-25-000123.md) | [2.3](/filings/0000107263-25-000145.md) | [3.2](/filings/0000107263-26-000026.md) | [3.3](/filings/0000107263-26-000017.md) | [3.1](/filings/0000107263-26-000026.md) |
| Total assets | $bn | [50.8](/filings/0000107263-23-000027.md) | [52.6](/filings/0000107263-26-000006.md) | [52.7](/filings/0000107263-24-000063.md) | [52.4](/filings/0000107263-24-000077.md) | [53.8](/filings/0000107263-24-000095.md) | [54.5](/filings/0000107263-26-000006.md) | [54.9](/filings/0000107263-25-000102.md) | [56.1](/filings/0000107263-25-000123.md) | [55.7](/filings/0000107263-25-000145.md) | [58.6](/filings/0000107263-26-000026.md) | [59.6](/filings/0000107263-26-000017.md) | [60.6](/filings/0000107263-26-000026.md) |
| Current liabilities | $bn | [5.5](/filings/0000107263-23-000027.md) | [5.8](/filings/0000107263-25-000031.md) | [5.0](/filings/0000107263-24-000063.md) | [4.7](/filings/0000107263-24-000077.md) | [4.7](/filings/0000107263-24-000095.md) | [5.3](/filings/0000107263-26-000006.md) | [6.3](/filings/0000107263-25-000102.md) | [6.0](/filings/0000107263-25-000123.md) | [5.4](/filings/0000107263-25-000145.md) | [6.1](/filings/0000107263-26-000026.md) | [4.0](/filings/0000107263-26-000017.md) | [6.5](/filings/0000107263-26-000026.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [0.0](/filings/0000107263-23-000027.md) | [0.7](/filings/0000107263-25-000031.md) | [0.0](/filings/0000107263-24-000063.md) | [0.6](/filings/0000107263-24-000077.md) | [0.0](/filings/0000107263-24-000095.md) | [0.5](/filings/0000107263-26-000006.md) | [0.3](/filings/0000107263-25-000102.md) | [0.0](/filings/0000107263-25-000123.md) | [0.2](/filings/0000107263-25-000145.md) | [0.7](/filings/0000107263-26-000026.md) | [0.0](/filings/0000107263-26-000017.md) | [0.5](/filings/0000107263-26-000026.md) |
| Shareholders' equity | $bn | [11.8](/filings/0000107263-23-000027.md) | [12.4](/filings/0000107263-25-000031.md) | [12.4](/filings/0000107263-24-000063.md) | [12.3](/filings/0000107263-24-000077.md) | [12.4](/filings/0000107263-24-000095.md) | [12.4](/filings/0000107263-26-000006.md) | [12.5](/filings/0000107263-25-000102.md) | [12.4](/filings/0000107263-25-000123.md) | [12.5](/filings/0000107263-25-000145.md) | [12.8](/filings/0000107263-26-000026.md) | [13.0](/filings/0000107263-26-000017.md) | [13.2](/filings/0000107263-26-000026.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,234 d](/filings/0000107263-24-000095.md) | [1,813 d](/filings/0000107263-26-000006.md) | [1,234](/filings/0000107263-25-000102.md) | [1,279 d](/filings/0000107263-25-000123.md) | [1,243 d](/filings/0000107263-25-000145.md) | [1,218 d](/filings/0000107263-26-000006.md) | [1,433](/filings/0000107263-26-000017.md) | [1,450 d](/filings/0000107263-26-000026.md) | [1,439 d](/filings/0000107263-25-000145.md) | [1,576 d](/filings/0000107263-26-000006.md) | [1,603](/filings/0000107263-26-000017.md) | [1,376 d](/filings/0000107263-26-000026.md) |
| Capital expenditure | $m | [690 d](/filings/0000107263-24-000095.md) | [671 d](/filings/0000107263-26-000006.md) | [544](/filings/0000107263-25-000102.md) | [579 d](/filings/0000107263-25-000123.md) | [682 d](/filings/0000107263-25-000145.md) | [768 d](/filings/0000107263-26-000006.md) | [1,012](/filings/0000107263-26-000017.md) | [972 d](/filings/0000107263-26-000026.md) | [954 d](/filings/0000107263-25-000145.md) | [1,955 d](/filings/0000107263-26-000006.md) | [1,359](/filings/0000107263-26-000017.md) | [1,834 d](/filings/0000107263-26-000026.md) |
| Dividends paid | $m | [544 d](/filings/0000107263-24-000095.md) | [544 d](/filings/0000107263-26-000006.md) | [579](/filings/0000107263-25-000102.md) | [579 d](/filings/0000107263-25-000123.md) | [579 d](/filings/0000107263-25-000145.md) | [579 d](/filings/0000107263-26-000006.md) | [610](/filings/0000107263-26-000017.md) | [611 d](/filings/0000107263-26-000026.md) | [611 d](/filings/0000107263-25-000145.md) | [610 d](/filings/0000107263-26-000006.md) | [642](/filings/0000107263-26-000017.md) | [642 d](/filings/0000107263-26-000026.md) |
| Share repurchases | $m | [0.0 d](/filings/0000107263-24-000095.md) | [0.0 d](/filings/0000107263-26-000006.md) | [0.0](/filings/0000107263-24-000063.md) | [0.0 d](/filings/0000107263-24-000077.md) | [0.0 d](/filings/0000107263-24-000095.md) | [0.0 d](/filings/0000107263-26-000006.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,222](/filings/0000107263-23-000027.md) | [1,226](/filings/0000107263-24-000063.md) | [1,220](/filings/0000107263-24-000077.md) | [1,220](/filings/0000107263-24-000095.md) | [1,222](/filings/0000107263-25-000102.md) | [1,222](/filings/0000107263-25-000123.md) | [1,223](/filings/0000107263-25-000145.md) | [1,225](/filings/0000107263-26-000017.md) | [1,224](/filings/0000107263-26-000026.md) | [1,225](/filings/0000107263-25-000145.md) | [1,226](/filings/0000107263-26-000017.md) | [1,225](/filings/0000107263-26-000026.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,223,167,472 at 2026-07-30, from the cover of the [10-Q filed 2026-08-03](/filings/0000107263-26-000026.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.